| Factor Information | |
|---|---|
| Data ID | 3693 |
| Factor | warfarin |
| Description | Univariate analyses showed that female patients (p = 0.009) and those receiving warfarin (p = 0.002) had increased risk of postoperative pericardial effusion. Multivariate logistic regression similarly identified warfarin treatment (β = 1.73, p = 0.009) and female sex (β for male = -0.63, p = 0.037) as significant determinants. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | risk of postoperative pericardial effusion. |
| p Value | <0.01 |
| Conclusion | Pericardial effusion occurs commonly after open heart surgery for congenital heart disease. Serial echocardiographic monitoring up to 28 days postoperatively is indicated in selected high risk patients such as those with symptoms of postpericardiotomy syndrome and those given warfarin. |
| Risk Factor | risk factor (article mentioned) |
| CHD Type | |
|---|---|
| ID | 689 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
| Reference | |
|---|---|
| PMID | 12807856 |
| Year | 2003 |
| Title | Pericardial effusion after open heart surgery for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | neonates/children/adults | |
| Source | N/A | |
| Region | Hong Kong, China | |
| Method | Hewlett-Packard ultrasound machine (Sonos 1500 or 5500) to assess development of pericardial effusion. Pericardial effusion was assessed in the standard parasternal short axis, long axis, apical four chamber, and subcostal views. | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | open heart surgery | |
| Group | Effusion present(Treatment) | Effusion absent(Control) |
| Number | 10 (total: 77) | 8 (total: 259) |
| Age | 2.3 (0.02-20.1) years | 1.7 (0-22.3) years |
| Gender (Male: Female) | 27:50 | 136:123 |
| Marker Level | 0.13 | 0.03 |
